487 related articles for article (PubMed ID: 11923424)
1. Cdk5/p35 regulates neurotransmitter release through phosphorylation and downregulation of P/Q-type voltage-dependent calcium channel activity.
Tomizawa K; Ohta J; Matsushita M; Moriwaki A; Li ST; Takei K; Matsui H
J Neurosci; 2002 Apr; 22(7):2590-7. PubMed ID: 11923424
[TBL] [Abstract][Full Text] [Related]
2. Influence of phosphorylation of p35, an activator of cyclin-dependent kinase 5 (cdk5), on the proteolysis of p35.
Kerokoski P; Suuronen T; Salminen A; Soininen H; Pirttilä T
Brain Res Mol Brain Res; 2002 Oct; 106(1-2):50-6. PubMed ID: 12393264
[TBL] [Abstract][Full Text] [Related]
3. The effect of Cyclin-dependent kinase 5 on voltage-dependent calcium channels in PC12 cells varies according to channel type and cell differentiation state.
Furusawa K; Asada A; Saito T; Hisanaga S
J Neurochem; 2014 Aug; 130(4):498-506. PubMed ID: 24766160
[TBL] [Abstract][Full Text] [Related]
4. Roscovitine: a novel regulator of P/Q-type calcium channels and transmitter release in central neurons.
Yan Z; Chi P; Bibb JA; Ryan TA; Greengard P
J Physiol; 2002 May; 540(Pt 3):761-70. PubMed ID: 11986366
[TBL] [Abstract][Full Text] [Related]
5. Enhanced activation of Ca2+/calmodulin-dependent protein kinase II upon downregulation of cyclin-dependent kinase 5-p35.
Hosokawa T; Saito T; Asada A; Ohshima T; Itakura M; Takahashi M; Fukunaga K; Hisanaga S
J Neurosci Res; 2006 Sep; 84(4):747-54. PubMed ID: 16802322
[TBL] [Abstract][Full Text] [Related]
6. Regulation of exocytosis by cyclin-dependent kinase 5 via phosphorylation of Munc18.
Fletcher AI; Shuang R; Giovannucci DR; Zhang L; Bittner MA; Stuenkel EL
J Biol Chem; 1999 Feb; 274(7):4027-35. PubMed ID: 9933594
[TBL] [Abstract][Full Text] [Related]
7. p35, the neuronal-specific activator of cyclin-dependent kinase 5 (Cdk5) is degraded by the ubiquitin-proteasome pathway.
Patrick GN; Zhou P; Kwon YT; Howley PM; Tsai LH
J Biol Chem; 1998 Sep; 273(37):24057-64. PubMed ID: 9727024
[TBL] [Abstract][Full Text] [Related]
8. Presynaptic Ca2+ channels and neurotransmitter release at the terminal of a mouse cortical neuron.
Qian J; Noebels JL
J Neurosci; 2001 Jun; 21(11):3721-8. PubMed ID: 11356859
[TBL] [Abstract][Full Text] [Related]
9. GSK-3 beta inhibits presynaptic vesicle exocytosis by phosphorylating P/Q-type calcium channel and interrupting SNARE complex formation.
Zhu LQ; Liu D; Hu J; Cheng J; Wang SH; Wang Q; Wang F; Chen JG; Wang JZ
J Neurosci; 2010 Mar; 30(10):3624-33. PubMed ID: 20219996
[TBL] [Abstract][Full Text] [Related]
10. Slowed N-type calcium channel (CaV2.2) deactivation by the cyclin-dependent kinase inhibitor roscovitine.
Buraei Z; Anghelescu M; Elmslie KS
Biophys J; 2005 Sep; 89(3):1681-91. PubMed ID: 15951378
[TBL] [Abstract][Full Text] [Related]
11. Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5.
Meijer L; Borgne A; Mulner O; Chong JP; Blow JJ; Inagaki N; Inagaki M; Delcros JG; Moulinoux JP
Eur J Biochem; 1997 Jan; 243(1-2):527-36. PubMed ID: 9030781
[TBL] [Abstract][Full Text] [Related]
12. A biochemical approach to study sub-second endogenous release of diverse neurotransmitters from central nerve terminals.
Leenders AG; Hengst P; Lopes da Silva FH; Ghijsen WE
J Neurosci Methods; 2002 Jan; 113(1):27-36. PubMed ID: 11741718
[TBL] [Abstract][Full Text] [Related]
13. The cyclin-dependent kinase 5 activators p35 and p39 interact with the alpha-subunit of Ca2+/calmodulin-dependent protein kinase II and alpha-actinin-1 in a calcium-dependent manner.
Dhavan R; Greer PL; Morabito MA; Orlando LR; Tsai LH
J Neurosci; 2002 Sep; 22(18):7879-91. PubMed ID: 12223541
[TBL] [Abstract][Full Text] [Related]
14. The regulation of cyclin-dependent kinase 5 activity through the metabolism of p35 or p39 Cdk5 activator.
Hisanaga S; Saito T
Neurosignals; 2003; 12(4-5):221-9. PubMed ID: 14673209
[TBL] [Abstract][Full Text] [Related]
15. Dual action of cyclin-dependent kinase inhibitors: induction of cell cycle arrest and apoptosis. A comparison of the effects exerted by roscovitine and cisplatin.
Wesierska-Gadek J; Gueorguieva M; Horky M
Pol J Pharmacol; 2003; 55(5):895-902. PubMed ID: 14704484
[TBL] [Abstract][Full Text] [Related]
16. Cyclin-dependent kinase 5 phosphorylates the N-terminal domain of the postsynaptic density protein PSD-95 in neurons.
Morabito MA; Sheng M; Tsai LH
J Neurosci; 2004 Jan; 24(4):865-76. PubMed ID: 14749431
[TBL] [Abstract][Full Text] [Related]
17. Cyclin-dependent kinase 5 regulates dopaminergic and glutamatergic transmission in the striatum.
Chergui K; Svenningsson P; Greengard P
Proc Natl Acad Sci U S A; 2004 Feb; 101(7):2191-6. PubMed ID: 14769920
[TBL] [Abstract][Full Text] [Related]
18. Differential Ca2+-dependence of transmitter release mediated by P/Q- and N-type calcium channels at neonatal rat neuromuscular junctions.
Rosato-Siri MD; Piriz J; Tropper BA; Uchitel OD
Eur J Neurosci; 2002 Jun; 15(12):1874-80. PubMed ID: 12099893
[TBL] [Abstract][Full Text] [Related]
19. CDK5 regulates cell-cell and cell-matrix adhesion in human keratinocytes.
Nakano N; Nakao A; Ishidoh K; Tsuboi R; Kominami E; Okumura K; Ogawa H
Br J Dermatol; 2005 Jul; 153(1):37-45. PubMed ID: 16029324
[TBL] [Abstract][Full Text] [Related]
20. Deletion of Cav2.1(alpha1(A)) subunit of Ca2+-channels impairs synaptic GABA and glutamate release in the mouse cerebellar cortex in cultured slices.
Lonchamp E; Dupont JL; Doussau F; Shin HS; Poulain B; Bossu JL
Eur J Neurosci; 2009 Dec; 30(12):2293-307. PubMed ID: 20092572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
